Bruce A. Schmidt
Direktor/Vorstandsmitglied bei VANCORD CAPITAL INC.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Robert de Wit | M | - |
WUTIF Capital (VCC), Inc.
 WUTIF Capital (VCC), Inc. Investment ManagersFinance WUTIF Capital (VCC), Inc seeks investment in technology companies located in British Columbia. The fund targets companies operating in the fields of communications and information technology, health and life sciences technologies, physical sciences, energy and fuel cells. It provides financing for seed and early stage capital requirements with investment size ranging from USD 25,000 to 250,000 and also co-invests with others. | 7 Jahre |
| Michael Volker | M | 76 |
WUTIF Capital (VCC), Inc.
WUTIF Capital (VCC), Inc. Investment ManagersFinance WUTIF Capital (VCC), Inc seeks investment in technology companies located in British Columbia. The fund targets companies operating in the fields of communications and information technology, health and life sciences technologies, physical sciences, energy and fuel cells. It provides financing for seed and early stage capital requirements with investment size ranging from USD 25,000 to 250,000 and also co-invests with others.
WUTIF Management Corp.
 WUTIF Management Corp. Investment ManagersFinance WUTIF Management Corp (WUTIF) is an independent venture capital firm founded in 2003. The firm is headquartered in Canada. | 21 Jahre |
| Robert I. Attwell | M | - |
myBestHelper Solution, Inc.
 myBestHelper Solution, Inc. Internet Software/ServicesTechnology Services myBestHelper Solution, Inc. owns and operates an online platform to connect families and helpers in Canada. It enables families to find and manage babysitters, nannies, and housecleaners, as well as helpers for home, child, and elder care. The company was founded in 2011 by Alexandra T. Greenhill and Rob Attwell and is headquartered in Vancouver, Canada. | 13 Jahre |
| Alexandra Greenhill | M | - |
myBestHelper Solution, Inc.
myBestHelper Solution, Inc. Internet Software/ServicesTechnology Services myBestHelper Solution, Inc. owns and operates an online platform to connect families and helpers in Canada. It enables families to find and manage babysitters, nannies, and housecleaners, as well as helpers for home, child, and elder care. The company was founded in 2011 by Alexandra T. Greenhill and Rob Attwell and is headquartered in Vancouver, Canada. | 13 Jahre |
| Richard Genovese | M | 69 | 15 Jahre | |
| Tim David Collings | M | - |
WUTIF Management Corp.
WUTIF Management Corp. Investment ManagersFinance WUTIF Management Corp (WUTIF) is an independent venture capital firm founded in 2003. The firm is headquartered in Canada. | 21 Jahre |
| Frank D. Anderson | M | 64 | 15 Jahre | |
| Kirk Hamilton | M | - |
WUTIF Management Corp.
WUTIF Management Corp. Investment ManagersFinance WUTIF Management Corp (WUTIF) is an independent venture capital firm founded in 2003. The firm is headquartered in Canada. | 5 Jahre |
| Gordon D. Skene | M | - |
WUTIF Management Corp.
WUTIF Management Corp. Investment ManagersFinance WUTIF Management Corp (WUTIF) is an independent venture capital firm founded in 2003. The firm is headquartered in Canada. | 21 Jahre |
| Gregory J. Sprung | M | - |
BC Mental Health Foundation
| - |
| Aaron Stuart | M | - |
WUTIF Management Corp.
WUTIF Management Corp. Investment ManagersFinance WUTIF Management Corp (WUTIF) is an independent venture capital firm founded in 2003. The firm is headquartered in Canada. | 7 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Robert Rosner | M | 59 | - | |
| David Alley | M | - | 1 Jahre | |
| Rosemonde Mandeville | M | - |
Biophage Pharma, Inc.
 Biophage Pharma, Inc. Pharmaceuticals: MajorHealth Technology Biophage Pharma, Inc. is a biotechnology company. It develops phage-based products and technologies for the detection, prevention and control of bacterial infections. It operates through two divisions: Therapeutic and Biosensors. The Therapeutic division is engaged in the management of bacterial contaminations in the medical, veterinary and environmental. The Biosensors division is to the development and commercialization of novel biosensors. Biophage Pharma was founded in 1995 and is headquartered in Montreal, Canada. | - |
| Janis D. Douville | F | - |
Medusa Style Corp.
| 5 Jahre |
| Terrance Owen | M | 77 |
University of British Columbia
| 17 Jahre |
| James DeMesa | M | 66 |
MIGENIX, Inc.
 MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | 7 Jahre |
| Ronald J. Zokol | M | 74 |
University of British Columbia
| 14 Jahre |
| John William Greenslade | M | 75 |
University of British Columbia
| 9 Jahre |
| Doug Johnson | M | - |
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | 2 Jahre |
| Chester Shynkaryk | M | 79 | 3 Jahre | |
| Ossama R. Hassanein | M | - |
University of British Columbia
| 4 Jahre |
| Pieter Dorsman | M | - |
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | 2 Jahre |
| Andrew J. Rae | M | - |
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | 2 Jahre |
| James David Pratt | M | - | 7 Jahre | |
| Alistair Duncan | M | - |
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | 6 Jahre |
| Yung Tan Chen | M | 62 | 12 Jahre | |
| Douglas Eacrett | M | 78 |
University of British Columbia
| 6 Jahre |
| David de Witt | M | 71 |
University of British Columbia
| 7 Jahre |
| David Schwartz | M | - |
University of British Columbia
| 5 Jahre |
| Donald Gordon | M | 68 | 3 Jahre | |
| David Nairne | M | - |
University of British Columbia
| 5 Jahre |
| Paul Brennan | M | - |
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | 1 Jahre |
| Jack H. L. Miller | M | - |
University of British Columbia
| 6 Jahre |
| Allan H. Shapiro | M | - | - | |
| Michael Edward O'Connor | M | - |
University of British Columbia
| 4 Jahre |
| Gordon William Blankstein | M | 73 |
University of British Columbia
| 7 Jahre |
| Glenn Yeadon | M | 73 |
University of British Columbia
| 5 Jahre |
| Eugene Hodgson | M | 67 | 7 Jahre | |
| AnnKatrin Petersen-Jappelli | M | - |
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | 4 Jahre |
| James Robertson | M | - |
University of British Columbia
| 6 Jahre |
| Ted Cohen | M | 74 | - | |
| P. Reifel | M | 72 |
University of British Columbia
| 6 Jahre |
| Gordon Ellis | M | 77 |
University of British Columbia
| 6 Jahre |
| Thomas Beattie | M | - |
University of British Columbia
| 5 Jahre |
| Leanne Bate | F | - |
PNO Resources Ltd.
 PNO Resources Ltd. Other Metals/MineralsNon-Energy Minerals PNO Resources Ltd. engages in the acquisition and exploration of natural resource properties. The company was founded on February 22, 1983 and is headquartered in Vancouver, Canada. | 7 Jahre |
| John H. Caton | M | - | - | |
| Linda J. Allison | M | 76 | 9 Jahre | |
| Ryan Schmidt | M | - | - | |
| Ronald Tysoe | M | 71 |
University of British Columbia
| 5 Jahre |
| John W. Commissiong | M | 79 |
PNO Resources Ltd.
PNO Resources Ltd. Other Metals/MineralsNon-Energy Minerals PNO Resources Ltd. engages in the acquisition and exploration of natural resource properties. The company was founded on February 22, 1983 and is headquartered in Vancouver, Canada. | - |
| James Dean | M | - | - | |
| Dae-Ryun Jang | M | 67 |
University of British Columbia
| 4 Jahre |
| Robin Hutchison | M | 68 |
University of British Columbia
| 4 Jahre |
| Georgios Polyhronopoulos | M | 66 |
University of British Columbia
| 4 Jahre |
| David L. Adderley | M | 68 |
University of British Columbia
| 4 Jahre |
| Ron Anderson | M | - |
University of British Columbia
| 4 Jahre |
| Murray L. Swales | M | 73 |
University of British Columbia
| 4 Jahre |
| Gordon R. Osinchuk | M | - |
University of British Columbia
| 4 Jahre |
| John E. Boddie | M | 72 |
University of British Columbia
| 4 Jahre |
| Ferdinand Lobkowicz | M | - |
University of British Columbia
| 4 Jahre |
| Douglas Buchanan | M | - |
University of British Columbia
| 4 Jahre |
| David Christie | M | 77 |
University of British Columbia
| 4 Jahre |
| Richard P. Schutte | M | - |
University of British Columbia
| 4 Jahre |
| Howie Young | M | - |
University of British Columbia
| 4 Jahre |
| David A. Yeager | M | - |
University of British Columbia
| 4 Jahre |
| Richard E. Fortescue | M | 70 |
University of British Columbia
| 4 Jahre |
| Mark Ralston | M | 71 |
University of British Columbia
| 4 Jahre |
| Karen L. Danielson | F | - |
University of British Columbia
| 4 Jahre |
| Gary Moore | M | - |
University of British Columbia
| 4 Jahre |
| Beverley Briscoe | F | 69 |
University of British Columbia
| 4 Jahre |
| Teh Ming Kwauk | M | 71 |
University of British Columbia
| 24 Jahre |
| Hon Cheung So | M | 68 |
University of British Columbia
| 4 Jahre |
| Glen MacDonald | M | 75 |
University of British Columbia
| 4 Jahre |
| Donald Gee | M | 73 |
University of British Columbia
| 4 Jahre |
| Christopher F. Yee | M | 66 |
University of British Columbia
| 4 Jahre |
| Ross Beaty | M | 72 |
University of British Columbia
| 4 Jahre |
| Yvan Joseph Bourdeau | M | - |
University of British Columbia
| 2 Jahre |
| Dave Jiles | M | - |
University of British Columbia
| 4 Jahre |
| Arthur James Mcfaull | M | - |
University of British Columbia
| 4 Jahre |
| Carl G. Verley | M | - |
University of British Columbia
| 4 Jahre |
| Ian D. Power | M | - |
University of British Columbia
| 4 Jahre |
| Robert George Lewis | M | - |
University of British Columbia
| 3 Jahre |
| Guy Gordon | M | - |
University of British Columbia
| 4 Jahre |
| Greg Peet | M | 70 |
University of British Columbia
| 5 Jahre |
| Ronald Ewing | M | - |
University of British Columbia
| 4 Jahre |
| Bob Bebluk | M | - |
University of British Columbia
| 6 Jahre |
| Wan H. Jung | M | 67 |
University of British Columbia
| 4 Jahre |
| Martin John Gardner Glynn | M | 72 |
University of British Columbia
| 2 Jahre |
| Deborah E. Fortescue-Merrin | F | 68 |
University of British Columbia
| 4 Jahre |
| John Blanchflower | M | - |
University of British Columbia
| 4 Jahre |
| Neville Desmond Smith | M | 71 |
University of British Columbia
| 4 Jahre |
| Peter M. Holbek | M | - |
University of British Columbia
| 6 Jahre |
| J. Peter Campbell | M | - |
University of British Columbia
| 4 Jahre |
| Andre J. Audet | M | - |
University of British Columbia
| 4 Jahre |
| David Lyall | M | 68 |
University of British Columbia
| 4 Jahre |
| James Albert Turner | M | 75 |
University of British Columbia
| 4 Jahre |
| Lam Sin Lai Tsui | M | 69 |
University of British Columbia
| 4 Jahre |
| Terry Krepiakevich | M | 71 |
University of British Columbia
| 4 Jahre |
| Charles MaLette | M | 78 |
University of British Columbia
| 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Kanada | 94 | 94,00% |
| Vereinigte Staaten | 6 | 6,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Bruce A. Schmidt
- Persönliches Netzwerk
